Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Sullivan

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Journal of Substance Abuse Treatment|February 25, 2014
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Archives of General Psychiatry|February 8, 2006
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trialSandra D Comer, Maria A Sullivan, Elmer Yu, et al.
Drug and Alcohol Dependence|October 7, 2014
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?Meredith A Kelly, Martina Pavlicova, Andrew Glass, et al.
Psychopharmacology|October 28, 2009
Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteersSandra D Comer, Ziva D Cooper, William J Kowalczyk, et al.
The American Journal on Addictions|May 9, 2008
Dextromethorphan and quinidine combination for heroin detoxificationEvaristo Akerele, Adam Bisaga, Maria A Sullivan, et al.
Addiction (Abingdon, England)|April 21, 2010
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusersSandra D Comer, Maria A Sullivan, Suzanne K Vosburg, et al.
The American Journal on Addictions|April 5, 2020
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition RegimensSandra D Comer, Paolo Mannelli, Danesh Alam, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 18, 2009
Betting on change: modeling transitional probabilities to guide therapy development for opioid dependenceKenneth M Carpenter, Huiping Jiang, Maria A Sullivan, et al.
The American Journal on Addictions|August 16, 2011
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekersElias Dakwar, Edward V Nunes, Adam Bisaga, et al.
Drug and Alcohol Dependence|January 4, 2015
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMaria A Sullivan, Adam Bisaga, Andrew Glass, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Journal of Substance Abuse Treatment|February 25, 2014
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Archives of General Psychiatry|February 8, 2006
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trialSandra D Comer, Maria A Sullivan, Elmer Yu, et al.
Drug and Alcohol Dependence|October 7, 2014
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?Meredith A Kelly, Martina Pavlicova, Andrew Glass, et al.
Psychopharmacology|October 28, 2009
Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteersSandra D Comer, Ziva D Cooper, William J Kowalczyk, et al.
The American Journal on Addictions|May 9, 2008
Dextromethorphan and quinidine combination for heroin detoxificationEvaristo Akerele, Adam Bisaga, Maria A Sullivan, et al.
Addiction (Abingdon, England)|April 21, 2010
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusersSandra D Comer, Maria A Sullivan, Suzanne K Vosburg, et al.
The American Journal on Addictions|April 5, 2020
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition RegimensSandra D Comer, Paolo Mannelli, Danesh Alam, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 18, 2009
Betting on change: modeling transitional probabilities to guide therapy development for opioid dependenceKenneth M Carpenter, Huiping Jiang, Maria A Sullivan, et al.
The American Journal on Addictions|August 16, 2011
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekersElias Dakwar, Edward V Nunes, Adam Bisaga, et al.
Drug and Alcohol Dependence|January 4, 2015
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMaria A Sullivan, Adam Bisaga, Andrew Glass, et al.
Pageof 9